Take the Assessment State-appropriate licensing
Find Out If Wegovy is Clinically Suitable Clinician-led medical assessment Personalised dosing and nutrition support Ongoing clinical monitoring throughout treatment How Wegovy Works to Reduce Appetite Wegovy (semaglutide) is a GLP-1 receptor agonist, which means it works by mimicking a naturally occurring hormone in the body
Nonetheless, if you're taking any prescription medication and considering adding a supplement, the conversation should happen with your prescribing provider before you start - not after
Acute or short term side effects may include: Stomach or abdominal pain Nausea or stomach upset Indigestion Constipation Headache Dizziness Drowsiness Fatigue Tinnitus Fluid retention Long term side effects may include: Chronic stomach pain, heartburn, or nausea Increased risk of gastrointestinal bleeding Small bowel inflammation (1) Increased risk of stomach ulcers Increased risk of heart disease and cardiovascular events including heart attack, stroke, and heart failure Increased risk of kidney disease or kidney failure Neither of these are complete lists, and some people may be at a higher risk of experiencing serious side effects
However, the CMS BALANCE model and the Medicare GLP-1 Bridge program launching in July 2026 will begin providing limited coverage for eligible beneficiaries with specific comorbidities at a $50 monthly copay